Intellia Therapeutics, Inc.NTLANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-617.14%
Near historical average
Percentile
P36
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-575.79%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -617.14% | +31.8% |
| 2024 | -905.33% | +35.1% |
| 2023 | -1395.77% | -61.5% |
| 2022 | -864.51% | -9.5% |
| 2021 | -789.52% | -251.5% |
| 2020 | -224.63% | +3.9% |
| 2019 | -233.81% | +17.6% |
| 2018 | -283.91% | -11.4% |
| 2017 | -254.86% | -35.2% |
| 2016 | -188.45% | - |